disitamab vedotin
rongchang pharma,seagen
['urothelial']
a phase ii study of rc48-adc in her2-negative patients with locally advanced or metastatic #urothelialcarcinoma. presentation by huayan xu, md. #asco22 written coverage by on urotoday &gt; 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology